Clinical Trial

PopSci CHW4CervixHealth

Recruiting
View on ClinicalTrials.gov →
Summary
Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening intervention aimed to promote HPV self-collection uptake among screening-eligible and under-screened ethnic minority women in the community.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07-01 -> 2026-10-01 2026-08-12
minor Completion pushed: 2026-07-01 -> 2026-10-01 2026-08-12
Trial Details
NCT Number NCT07336134
Lead Sponsor Thomas Jefferson University
Collaborators: Roche Pharma AG
Conditions Cervical Cancer, Hpv, Human Papilloma Virus, HPV Infection
Enrollment 120 participants
Start Date 2025-10-22
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11